These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12673555)

  • 61. [Pathologic analysis of upper tract urothelial carcinomas: state of the art review for the yearly scientific report of the French National Association of Urology].
    Varinot J; Colin P; Rouprêt M; Leroy X; Comperat E
    Prog Urol; 2014 Nov; 24(15):954-65. PubMed ID: 25199727
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Microsatellite instability in transitional cell carcinoma of the urinary tract and its relationship to clinicopathological variables and smoking.
    Uchida T; Wang C; Wada C; Iwamura M; Egawa S; Koshiba K
    Int J Cancer; 1996 Apr; 69(2):142-5. PubMed ID: 8608983
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Recurring urothelial tumours of the urinary tract (author's transl)].
    Flamm J
    Wien Med Wochenschr; 1979 Oct; 129(19):535-40. PubMed ID: 516751
    [TBL] [Abstract][Full Text] [Related]  

  • 64. DNA repair genes and prognosis in sporadic forms of urothelial carcinoma of the upper urinary tract.
    García-Tello A; Ramón de Fata F; Andrés G; Ropero S; López JI; Angulo JC
    Actas Urol Esp; 2014 Nov; 38(9):600-7. PubMed ID: 24958312
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Hereditary nonpolyposis colorectal cancer syndrome in a patient with urothelial carcinoma of the upper urothelial tract.
    Hartmann A; Cheville JC; Dietmaier W; Hofstädter F; Burgart LJ; Blaszyk H
    Arch Pathol Lab Med; 2003 Feb; 127(2):E60-3. PubMed ID: 12562253
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Uroplakin III is a highly specific and moderately sensitive immunohistochemical marker for primary and metastatic urothelial carcinomas.
    Kaufmann O; Volmerig J; Dietel M
    Am J Clin Pathol; 2000 May; 113(5):683-7. PubMed ID: 10800401
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Inverted papillomas of the urinary tract. A case of multiple, recurring inverted papillomas of the renal pelvis, ureter and bladder associated with malignant change.
    Palvio DH
    Scand J Urol Nephrol; 1985; 19(4):299-302. PubMed ID: 4089556
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Infrequent alteration in the p53R2 gene in human transitional cell carcinoma of the urinary tract.
    Hayashi H; Furihata M; Kuwahara M; Kagawa S; Shuin T; Ohtsuki Y
    Pathobiology; 2004; 71(2):103-6. PubMed ID: 14707445
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A cribriform urothelial neoplasm of the renal pelvis: an adenoid cysticlike variant of inverted urothelial papilloma or florid ureteritis cystica?
    Talmon GA; Khan A; Koerber R; Lele S; Johansson S
    Arch Pathol Lab Med; 2010 Oct; 134(10):1557-9. PubMed ID: 20923313
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Urothelial neoplasia of the upper urinary tract.
    Chasko SB; Gray GF; McCarron JP
    Pathol Annu; 1981; 16(Pt 2):127-53. PubMed ID: 7329727
    [No Abstract]   [Full Text] [Related]  

  • 71. Molecular aspects of upper tract urothelial carcinoma.
    Patel N; Arya M; Muneer A; Powles T; Sullivan M; Hines J; Kelly J
    Urol Oncol; 2014 Jan; 32(1):28.e11-20. PubMed ID: 23428541
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Microsatellite instability as indicator of MSH2 gene mutation in patients with upper urinary tract transitional cell carcinoma.
    Roupret M; Catto J; Coulet F; Azzouzi AR; Amira N; Karmouni T; Fromont G; Sibony M; Vallancien G; Gattegno B; Meuth M; Hamdy FC; Cussenot O
    J Med Genet; 2004 Jul; 41(7):e91. PubMed ID: 15235034
    [No Abstract]   [Full Text] [Related]  

  • 73. Expression status of GATA3 and mismatch repair proteins in upper tract urothelial carcinoma.
    Wang Y; Zhang J; Wang Y; Wang S; Zhang Y; Miao Q; Gao F; He H
    Front Med; 2019 Dec; 13(6):730-740. PubMed ID: 31020542
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Towards a rational strategy for the surveillance of patients with Lynch syndrome (hereditary non-polyposis colon cancer) for upper tract transitional cell carcinoma.
    Acher P; Kiela G; Thomas K; O'Brien T
    BJU Int; 2010 Aug; 106(3):300-2. PubMed ID: 20553255
    [No Abstract]   [Full Text] [Related]  

  • 75. [Fundamental bases of urothelial carcinogenesis].
    Chopin D; Cappellen D; Fradvanyi F; Gattegno B
    Prog Urol; 2001 Nov; 11(5):879-924. PubMed ID: 11769084
    [No Abstract]   [Full Text] [Related]  

  • 76. [Carcinogenic pathways and natural history of upper tract urothelial carcinomas: state-of-the-art review for the yearly scientific report of the French National Association of Urology].
    Seisen T; Cancel-Tassin G; Colin P; Cussenot O; Rouprêt M
    Prog Urol; 2014 Nov; 24(15):943-53. PubMed ID: 25158326
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Urothelial tumor and colonic cancer in the context of a syndrome of hereditary predisposition to HNPCC colonic cancer].
    de la Taille A; Mariette C; Buisine MP; Biserte J; Triboulet JP
    Prog Urol; 2000 Dec; 10(6):1204-7. PubMed ID: 11217560
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Blood groups and urothelial tumours of the upper urinary tract. A study of 295 patients.
    Kvist E; Krogh J; Rye B
    Scand J Urol Nephrol; 1990; 24(4):253-5. PubMed ID: 2125744
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cytogenetic analysis of upper urinary tract transitional cell carcinomas.
    Fadl-Elmula I; Gorunova L; Mandahl N; Elfving P; Lundgren R; Rademark C; Heim S
    Cancer Genet Cytogenet; 1999 Dec; 115(2):123-7. PubMed ID: 10598145
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Multicentricity of urothelial tumors of the efferent urinary tracts].
    Flamm J
    Z Urol Nephrol; 1979 Mar; 72(3):201-8. PubMed ID: 463377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.